117 related articles for article (PubMed ID: 9164212)
21. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
22. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
[TBL] [Abstract][Full Text] [Related]
24. [Structural changes of tumor microenvironment in liver metastases of colorectal carcinoma].
Giuşcă SE; Carasevici E; Eloae-Zugun F; Târcoveanu E; Căruntu ID
Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):165-73. PubMed ID: 18677922
[TBL] [Abstract][Full Text] [Related]
25. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
Sinicrope FA; Hart J; Michelassi F; Lee JJ
Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
[TBL] [Abstract][Full Text] [Related]
27. Prognostic markers for colorectal cancer: expression of P53 and BCL2.
Pereira H; Silva S; Julião R; Garcia P; Perpétua F
World J Surg; 1997 Feb; 21(2):210-3. PubMed ID: 8995081
[TBL] [Abstract][Full Text] [Related]
28. Cell kinetics of colorectal liver metastases.
Silvestrini R; Costa A; Faranda A
Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S92-5. PubMed ID: 8313801
[TBL] [Abstract][Full Text] [Related]
29. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
30. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
EI-Emshaty HM; Saad EA; Toson EA; Abdel Malak CA; Gadelhak NA
Hepatogastroenterology; 2014; 61(133):1393-401. PubMed ID: 25436317
[TBL] [Abstract][Full Text] [Related]
32. P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection.
Heisterkamp J; van Bommel J; Hop WC; Tilanus HW; Zondervan PE; IJzermans JN
Hepatogastroenterology; 1999; 46(30):3109-14. PubMed ID: 10626170
[TBL] [Abstract][Full Text] [Related]
33. Biological prospectives to define prognosis and treatment strategies in liver metastases from colorectal cancer.
Silvestrini R; Costa A; Faranda A
Ann Ital Chir; 1996; 67(6):733-7. PubMed ID: 9125689
[TBL] [Abstract][Full Text] [Related]
34. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
[TBL] [Abstract][Full Text] [Related]
35. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
[TBL] [Abstract][Full Text] [Related]
36. Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas.
McKay JA; Lloret C; Murray GI; Johnston PG; Bicknell R; Ahmed FY; Cassidy J; McLeod HL
Int J Oncol; 2000 Jul; 17(1):153-8. PubMed ID: 10853033
[TBL] [Abstract][Full Text] [Related]
37. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
38. Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.
Schelwies K; Sturm I; Grabowski P; Scherübl H; Schindler I; Hermann S; Stein H; Buhr HJ; Riecken EO; Zeitz M; Dörken B; Daniel PT
Int J Cancer; 2002 Jun; 99(4):589-96. PubMed ID: 11992551
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic importance of selected molecular genetic immunohistochemical markers and DNA ploidy in endometrial cancer].
Kudela M; Pilka R; Lubuský M; Hejtmánek P; Dzubák P; Brychtová S
Ceska Gynekol; 2011 Jun; 76(3):194-9. PubMed ID: 21838149
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
